Business & Regulation

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…

Gearing up for 2019, the EMA shares revised guidelines to better protect the environment.

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?

Sitting Down With… Sir Alasdair Breckenridge; Chairman of the Advisory Board, the Centre of Regulatory Excellence of the Government of Singapore...

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

Here we discuss the problems of handling living, breathing cells in transit...